We found that Sema3d is low expressed in metastatic tumor and early recurrence (<2 years) of HCC tissues but relatively high expressed in late recurrence (>2 years) and nonrecurrence (in 60 months after surgery) of HCC tissues (Figure 2A). This evidence concerns the gene SEMA3D and hepatocellular carcinoma.